The genus decision: Potential impact on ophthalmic pharmaceuticals
Ocul Surf
.
2022 Oct:26:342-344.
doi: 10.1016/j.jtos.2022.08.006.
Epub 2022 Aug 17.
Authors
Gary D Novack
1
,
Kristin D Williams
2
Affiliations
1
Department of Ophthalmology & Visual Sciences, University of California, Davis, USA; PharmaLogic Development Inc., San Rafael, CA, USA. Electronic address: Gary_novack@Pharmalogic.com.
2
Lexitas Pharma Services, Inc., Durham, NC, USA.
PMID:
35985608
DOI:
10.1016/j.jtos.2022.08.006
No abstract available
Publication types
Letter
MeSH terms
Ophthalmic Solutions*
Pharmaceutical Preparations
Substances
Ophthalmic Solutions
Pharmaceutical Preparations